ESTRO 2022 - Abstract Book

S185

Abstract book

ESTRO 2022

.

Conclusion This pooled analysis of 5473 rectal cancer patients highlights and supports that early and intermediate endpoints could be considered surrogates of overall survival. This suggests that future clinical trials on rectal cancer could be designed using these early and intermediate endpoints as primary or secondary outcomes.

MO-0226 Clinical outcomes of HIV-positive patients with anal cancer in the ANABASE multicentric cohort

C. Evin 1 , L. Quéro 2 , K. Le Malicot 3 , S. Blanchet-Deverly 2 , E. François 4 , C. Buchalet 5 , C. Lemanski 5 , N. Baba Hamed 6 , E. Rivin del Campo 1 , L. Bauwens 7 , P. Pommier 7 , A. Lièvre 8 , D. Tougeron 9 , V. Macé 10 , G. Sergent 11 , O. Diaz 12 , D. Zucman 13 , F. Mornex 14 , C. Locher 15 , A. De la Rochefordière 16 , V. Vendrely 17 , F. Huguet 1